UnitedHealthCare | GenomeWeb

UnitedHealthCare

United Healthcare, Aetna, Cigna, and Anthem now cover the Harmony test, which predicts fetal risk for trisomies 21, 18, and 13.

The coverage is for Paradigm's PCDx test, and will extend to all patients insured by UnitedHealthcare throughout the United States.

Under a national agreement, UnitedHealthcare will cover the FoundationOne genomic profiling assay in patients with metastatic stage IV non-small cell lung cancer.

Good Start will serve as an in-network laboratory partner for a variety of genetic screening tests.

The agreement covers 43 million people in the US and includes Sequenom's MaterniT21 Plus and HerediT CF and Universal tests. 

The decision means that UnitedHealthcare's members will have access to Biodesix's test for advanced NSCLC as a covered benefit.

physician payment

Personalized medicines haven't been a big part of APMs to date, but the report suggests ways in which payment models might be structured to spur utilization.

NEW YORK (GenomeWeb) – With a series of recent payor decisions, Integrated Diagnostics now has more than 200 million covered lives for its Xpresys Lung cancer test.

NEW YORK (GenomeWeb) – NanoString Technologies said today that it has been told by Laboratory Corporation of America that UnitedHealthcare will reimburse for testing services from LabCorp based on NanoString's Prosigna Breast Cancer Gene Signature Assay.

NEW YORK (GenomeWeb) – Myriad Genetics is hoping that its recent coverage deal with national payor UnitedHealthcare for its next-generation sequencing myRisk Hereditary Cancer panel will offer a blueprint for other payors to follow suit.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.